PW01-021 – The phenotype of FMF due to deletion M694

por Lachmann, HJ, Rowczenio, DM, Gilbertson, JA, Gillmore, JD, Wechalekar, AD, Lane, T, Hawkins, PN
Publicado 2013

Empirical use of anakinra in AA amyloidosis of uncertain aetiology

por Lane, T, Rowczenio, DM, Gilbertson, JA, Gillmore, JD, Wechalekar, AD, Hawkins, PN, Lachmann, HJ
Publicado 2015

Diagnostic value of fat aspirates for amyloidosis in 950 patients

por Gilbertson, JA, Botcher, NA, Rowczenio, D, Whelan, C, Lachmann, HJ, Wechalekar, A, Gillmore, JD, Hawkins, PN
Publicado 2015

OR14-001 – Tocilizumab in autoinflammation and AA amyloidosis

por Lane, T, Gillmore, JD, Wechalekar, AD, Stewart, NM, Gilbertson, JA, Sachchithanantham, S, Rowczenio, DM, Banypersad, S, Pinney, JH, Mahmood, S, Lachmann, HJ, Hawkins, PN
Publicado 2013